aspartyl- arginyl- valyl- tyrosyl- isoleucyl- histidyl- prolyl- phenylalanyl- histidyl- leucyl- valyl- isoleucyl- histidine (hTDP)
a synthetic tridecapeptide corresponding to the N-terminal sequence of human angiotensinogen
Also Known As:
hTDP; Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His; DRVYIHPFHLVIH; human-type tridecapeptide
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Lee, Virginia M-Y:
2 articles
(10/2018 - 01/2016)
|
2. | Trojanowski, John Q:
2 articles
(10/2018 - 01/2016)
|
3. | Boeve, Bradley F:
1 article
(05/2020)
|
4. | Buciuc, Marina:
1 article
(05/2020)
|
5. | Dickson, Dennis W:
1 article
(05/2020)
|
6. | Ferman, Tanis J:
1 article
(05/2020)
|
7. | Fields, Julie A:
1 article
(05/2020)
|
8. | Graff-Radford, Jonathan:
1 article
(05/2020)
|
9. | Josephs, Keith A:
1 article
(05/2020)
|
10. | Kantarci, Kejal:
1 article
(05/2020)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures